A virological description of serous meningitis in childrenimmunized with vaccine against epidemic parotitis
- Issue: Vol 49, No 5 (2004)
- Pages: 28-32
- Section: Articles
- Submitted: 09.06.2023
- Published: 15.10.2004
- URL: https://virusjour.crie.ru/jour/article/view/11872
- ID: 11872
Cite item
Full Text
Abstract
The morbidity structure was analyzed in children vaccinated against epidemic parotitis in 1993-2002.
Eight children (4 with serous meningitis and 4 with lesions of the salivary glands) underwent virologic and immunologic
examinations. The molecular typing of the SH-gene fragment of the parotitis virus showed the process in 7 cases
to be provoked by the vaccination strain. Presumedly, progressing vaccine-associated meningitis inhibits antibody formation.
The total incidence of vaccine-associated meningitis was shown, according to Saint Petersburg
data, to be not high, which testifies to a low reactogenicity of the Russian vaccine strain.
Eight children (4 with serous meningitis and 4 with lesions of the salivary glands) underwent virologic and immunologic
examinations. The molecular typing of the SH-gene fragment of the parotitis virus showed the process in 7 cases
to be provoked by the vaccination strain. Presumedly, progressing vaccine-associated meningitis inhibits antibody formation.
The total incidence of vaccine-associated meningitis was shown, according to Saint Petersburg
data, to be not high, which testifies to a low reactogenicity of the Russian vaccine strain.
Keywords
References
- Аксенов О. А., Голева О. В., Скрипненко Н. В. и др. Новое в патогенезе развития осложнений при эпидемическом паротите у детей // Вопр. вирусол. - 2000. - № 4. - С. 24- 28.
- Клинико-лабораторные критерии диагностики, терапии и профилактики поствакцинальных осложнений: Пособие для врачей. - СПб., 2001.
- Максимова О. А., Попов В. Ф., Бектимиров Т. A. http:// www.bio.ru/staty-2.html (УГ МПБП: статьи). - С. 1-8.
- Попов В. Ф., Каппунова О. П., Юнасова Т. Н. К вопросу о качестве и эффективности отечественной живой паротитной вакцины // Журн. микробиол. - 1997. - № 2. - С. 51-53
- Adverse Events Associated with Childhood Vaccines. - Washington, 1994. - P. 118-186.
- Black S., Shinefield H., Ray P. et al. Risk of hospitalization because of aseptic meningitis after measles-mumps-rubella vaccination in one- to two-year-old children an analysis of the Vaccine Safety Datalink (VSD) Project // Pediatr. Infect. Dis. J. - 1997. - Vol. 16. - P. 500-503.
- Dourabo I., Cunha S., da Cloria Teixeira M. et al. Outbreak of aseptic meningitis associated with mass vaccination with a Urabe-containing measles-mumps-rubella vaccine: implications for immunization programs // Am. J. Epidemiol. - 2000. - Vol. 152. - P. 524-530.
- Galazka A. M. Mumps and mumps vaccine: global review // Bull. Wld Hlth Org. - 1999. - Vol. 77. - P. 38-46.
- Tesovic G., Begovac I., Bace A. Aseptic meningitis after measles, mumps, and rubella vaccine // Lancet. - 1993. - Vol. 341. - P. 1541.